Page last updated: 2024-10-28

heptaminol and Hypopigmentation

heptaminol has been researched along with Hypopigmentation in 1 studies

Heptaminol: An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.

Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.

Research Excerpts

ExcerptRelevanceReference
"This patient had chronic renal failure and had been undergoing hemodialysis since 2003."1.35Hair lightening in an hemodialysis patient treated by heptaminol (heptamyl). ( Benchikhi, H; Gharibi, L; Ramdani, B; Zouhair, K, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gharibi, L1
Zouhair, K1
Ramdani, B1
Benchikhi, H1

Other Studies

1 other study available for heptaminol and Hypopigmentation

ArticleYear
Hair lightening in an hemodialysis patient treated by heptaminol (heptamyl).
    Dermatology online journal, 2009, Apr-15, Volume: 15, Issue:4

    Topics: Adult; Hair Color; Heptaminol; Humans; Hypopigmentation; Hypotension; Kidney Failure, Chronic; Male;

2009